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C h r i s t i a n S t r e f f e r , Sieglinde Hengstebeck und Peter Tamulevicius 
I n s t i t u t f i i r Medizinische Strahlenphysik and S t r a h l e n b i o l o g i e 
U n i v e r s i t a t s k l i n i k u m Essen 
Hufelandstr. 55, D 4300 Essen I f W.-Germany 
Abstract 
G l y c o l y t i c metabolites such as glucose, glucose-6-phosphate, 
fructose-1.6-diphosphate, dihydroxyacetone-phosphate, g l y c e r o l - 3 -
phosphate, pyruvate and l a c t a t e as w e l l as acetoacetate and 6-
hydroxybutyrate were measured i n mouse l i v e r and adenocarcinoma 
a f t e r l o c a l hyperthermia f o r one hour at 43 °C and a glucose load 
of 6 mg/g body weight. 
The combined treatment led t o an increase of the l a c t a t e l e v e l , at 
the same time the glucose degradation was apparently enhanced. The 
r e d o x e q u i l i b r i a were s h i f t e d t o the reduced m e t a b o l i t e s . This could 
be i n t e r p r e t e d t h a t hypoxia was induced or enhanced, which could 
have s i g n i f i c a n c e f o r the tumor therapy. 
At l a t e r periods a f t e r hyperthermia a metabolic s i t u a t i o n occurred 
which was also observed i n severe diabetes. Such a l t e r a t i o n s which 
occurred also i n the l i v e r must be considered i n connection w i t h 
normal t i s s u e damage. 
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I n t r o d u c t i o n 
Metabolic pathways are very w e l l r e g u l a t e d . Temperature changes 
can a l t e r the r a t e of enrymatic r e a c t i o n s which can lead t o 
disorders of the whole pathway. At very high temperatures 
dena t u r a t i o n of p r o t e i n s occurs ( 1 ) . Damage t o cancer c e l l meta-
bolism by hyperthermia has been reported (2,3) . Von Ardenne has 
suggested t h a t the heat s e n s i t i v i t y of cancer c e l l s can be i n -
creased by glucose (4,5). I t i s assumed t h a t l a c t a t e accumulates 
under these c o n d i t i o n s and induces a decrease of the i n t r a c e l l u l a r 
pH-value. 
Other authors have shown t h a t the lowering of the pH-value causes 
a remarkable enhancement of c e l l k i l l i n g by hyperthermia ( 6 ) . 
Glucose metabolism i s exprem.ely complex and coupled i n several 
ways w i t h the described parameters. Therefore i t seemed of i n t e r e s t 
t o study glucose metabolism and i t s a l t e r a t i o n by hyperthermia i n 
an experimental tumor. Tumor therapy i s very s t r o n g l y l i n k e d t o the 
tolerance of normal t i s s u e s . As glucose m.etabolism i s e s p e c i a l l y 
a c t i v e i n l i v e r , hepatic t i s s u e i s included i n these s t u d i e s . 
M a t e r i a l s and Methods 
Inbred mice (C^ y^ black) were used f o r a l l experiments. An adenocar-
cinoma was t r a n s p l a n t e d i n t o these animals by i n j e c t i o n of a tumor 
c e l l suspension i n t o the muscles of the hind l e g . Six days a f t e r 
the t r a n s p l a n t a t i o n the animals were used f o r the experiments. For 
the studies of hyperthermia the hind leg w i t h the tumor was heated 
i n a water bath f o r one hour at 43 °C. During heating the animals 
were kept unter anaesthesia. I n some animals the temperature was 
measured i n the tumor and i n the neck of the animals. W i t h i n 10 
minutes the temperature increased from 35.2 °C t o 42.0 °C i n the 
tumor, a f t e r 30 minutes heating i t reached a value of 42.7 °C and 
stayed at t h i s temperature u n t i l the end of heating. A f t e r the 
heating the temperature decreased i n the tumor t o less than 30 °C 
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and remained at t h i s low l e v e l f o r several hours. I n the neck the 
temperature also increased t o 40.4 °C w i t h i n 30 minutes of heating 
at 4 3 °C. A f t e r the hypertherm.ic treatment the r e c t a l temperature 
decreased t o about 32 °C f o r several hours. 
For the metabolic determinations the l i v e r t i s s u e and tumor were 
taken o f f under anaesthesia, homogenized w i t h 4 percent p e r c h l o r i c 
acid and c e n t r i f u g e d . The supernatant was n e u t r a l i z e d and used f o r 
the determination of glucose, glucose-6-phosphate (G-6-P), f r u c t o s e -
1,6-diphosphate (FDP), dihydroxy-acetonephosphate (DAP), g l y c e r o l -
3-phosphate (G-3-P), pyruvate, l a c t a t e , acetoacetate (AcAc) and 
6-hydroxybutyrate (B-HO-Bu), The metabolites were measured by 
enzym.atic assays coupled t o NAD"^ or NADH. 
Glucose was i n j e c t e d i n t r a p e r i t o n e a l l y d i r e c t l y before the hyper-
thermia treatment (6 mg/g body w e i g h t ) . 
Results and Discussion 
A f t e r the i n t r a p e r i t o n e a l i n j e c t i o n of glucose i n a r a t h e r high 
dose (6 mg/g body weight = 33.4 y moles/g) the glucose l e v e l i n -
creased i n l i v e r t i s s u e very r a p i d l y and w i t h i n 10 minutes reached 
i t s highest l e v e l . 20 minutes a f t e r i n j e c t i o n the glucose l e v e l was 
about the same, 60 minutes a f t e r a d m i n i s t r a t i o n i t had decreased 
again (Table 1). Most of the measured g l y c o l y t i c metabolites were 
not considerably a l t e r e d i n the hepatic t i s s u e . Only pyruvate and 
l a c t a t e , the end products of g l y c o l y s i s were enhanced. 
When the l o c a l heating of the hind l e g w i t h the tumor (one hour 
at 43 °C) was s t a r t e d j u s t a f t e r the glucose i n j e c t i o n the glucose 
content was the same i n the l i v e r as wi t h o u t hyperthermia. However 
the l e v e l s of glycerol-3-phosphate, pyruvate, l a c t a t e and also 
6-hydroxybutyrate had increased under these c o n d i t i o n s . As mentioned 
e a r l i e r the l o c a l heating induced a r i s e of the temperature i n the 
whole mouse t o about 40 °C (Table 1) . These data dem,onstrate the 
d i f f i c u l t i e s i n e s t a b l i s h i n g a l o c a l heating of t i s s u e s and as a 
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consequence i n l o c a l i z i n g the e f f e c t s of hyperthermia t o the tumor. 
The problem of heat d i s s i p a t i o n i s e s p e c i a l l y acute w i t h smaller 
animals such as the mouse and w i l l be less serious i n c l i n i c a l 
tumor therapy, although i t also e x i s t s . 
I n the tumor t i s s u e the glucose content increased at about the same 
r a t e as i n the l i v e r . The highest l e v e l s were obtained 20 - 40 
minutes a f t e r the i n j e c t i o n (about 14 v' moles/g t i s s u e ) . The incrase 
of the l a c t a t e content was comparatively small i n the tumor. A 
s i m i l a r e f f e c t was observed f o r the l e v e l s of FDP and DAP (Table 2 ) . 
Hyperthermia led t o a decrease of the glucose content i n the tumor, 
also G-6-P was reduced. On the other hand an increase of G-3-P and 
6-hydroxybutyrate was observed d i r e c t l y a f t e r hyperthermia. S i m i l a r 
changes occurred when a glucose load was given t o the animals j u s t 
before the hyperthermia treatment was s t a r t e d . However under these 
c o n d i t i o n s (glucose plus hyperthermia) the l a c t a t e content was also 
enhanced i n the tumor d i r e c t l y a f t e r the hyperthermia treatment 
had ended. 
Dickson and Calderwood (8) observed an i n h i b i t i o n of g l y c o l y s i s i n 
Yoshida sarcoma of r a t s a f t e r hyperthermia treatment i n v i v o when 
the tumor t i s s u e was incubated i n v i t r o . Our data appeared not t o 
support such a mechanism f o r the p e r i o d during hyperthermia. The 
f i n d i n g t h a t the glucose l e v e l was lowered by hyperthermia demon-
s t r a t e d a more r a p i d glucose t u r n o v e r , i n other experiments i t could 
1 4 
be shown t h a t the output of CO2 by mice was increased d u r i n g whole 
body hyperthermia (1 hour at 40 °C or 41 °C) a f t e r i n j e c t i o n of 
r a d i o a c t i v e l y l a b e l l e d glucose (unpublished r e s u l t s ) . Further i t has 
been shown t h a t during whole body hyperthermia a considerable 
breakdown of hepatic glycogen occurred and no accumulation of glyco-
l y t i c m.etabolites was found (9) . However some hours a f t e r hyperther-
mia the metabolic degradation of glucose was apparently decreased. 
This e f f e c t was i n agreement w i t h the data of Dickson and Calderwood(8) 
and w i l l be discussed l a t e r . I t was f u r t h e r s u r p r i s i n g t h a t most of 
the g l y c o l y t i c metabolites increased only t o a small extent besides 
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l a c t a t e . A higher r i s e of G-6-P, FDP and DAP was seen i n r a t s w i t h 
a t r a n s p l a n t a b l e glioblastoma a f t e r chronic glucose i n f u s i o n which 
coincided w i t h a decrease of the pH-value (unpublished r e s u l t s ) . 
These data suggested t h a t i f an i n h i b i t i o n of glucose degradation 
occurred by hyperthermia i t may be t h a t the l a c t a t e consumption was 
somewhat reduced. 
Also i t should be mentioned t h a t hyperthermia plus glucose s h i f t e d 
the r e d o x e q u i l i b r i a i n t o the d i r e c t i o n of the reduced metabolites 
(Table 1 and 2 ) . This occurred f o r both the r a t i o s of lact a t e / p y r u v a t e 
and 6-hydroxybutyrate/acetoacetate e s p e c i a l l y i n the tumor. I t could 
mean t h a t hypoxia was induced or enhanced under these c o n d i t i o n s . 
I t f u r t h e r could have some relevance t o the pH-value through the 
f o l l o w i n g equation: 
[ l a c t a t e ] x [NAD"^] 
[pyruvate] x [NADH] HP] 
Analogous equations are v a l i d f o r the other r e d o x e q u i l i b r i a . Such 
changes would have a great s i g n i f i c a n c e f o r tumor therapy and must 
be i n v e s t i g a t e d i n the f u t u r e . 
I n f u r t h e r experiments the metabolites were measured over a period 
of several hours a f t e r hyperthermia treatment w i t h o u t glucose 
i n j e c t i o n (Table 3 ) . A strong decrease of the glucose content was 
observed which was followed by the other g l y c o l y t i c metabolites 
i n c l u d i n g l a c t a t e and pyruvate. During t h i s p e riod the C02-output 
from glucose was also diminished (unpublished r e s u l t s ) . However, two 
other strong a c i d i c m e t a b o l i t e s , acetoacetate and 6-hydroxybutyrate 
were g r e a t l y increased a f t e r hyperthermia. S i m i l a r observations 
were made i n the l i v e r t i s s u e of mice a f t e r whole body hyperthermia(9) . 
Thus a metabolic s i t u a t i o n occurred which was also found i n severe 
diabetes. The a c i d i c metabolites could be formed from glucose v i a 
l a c t a t e and acetyl-CoA. These metabolic a l t e r a t i o n s might also 
c o n t r i b u t e t o the l i v e r damage which was observed a f t e r c l i n i c a l 
a p p l i c a t i o n of hyperthermia. 
81 
Thus glucose matabolism might be i n t e r e s t i n g f o r two reasons: 
On the one hand the s e n s i t i v i t y of the tumor t i s s u e t o hyperthermia 
might be a l t e r e d . Blood flow and con c o m i t t a n t l y the oxygen supply 
can be i n f l u e n c e d . On the other hand hyperthermia could induce 
changes of the glucose metabolism f o r a longer period and these 
e f f e c t s could c o n t r i b u t e t o p a t h o p h y s i o l o g i c a l dam.age i n normal 
t i s s u e s . 
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Table 1 
Control Glucose 
10 minutes 
Glucose 
60 minutes 
Glucose and 
Hyperthermia 
60 minutes 
Glucose 10.2 + 0. 2 3 7 .0 -1- 3 . 0 23 .9 + 2 .0 23 .4 + 0, 1 
G-6-P 0. 36 -r 0. 01 0. 42 + 0. 02 0. 36 + 0 .02 0. 32 + 0. 02 
FDP 0.038 + 0. 003 0. 031 + 0. 002 0. 041 + 0 .02 0. 034 + 0. 002 
DAP 0.035 + 0. 001 0. 035 0. 002 0. 043 + 0 .02 0. 038 + 0. 002 
G-3-P 0.52 + 0. 02 0. 51 0. 02 0. 70 + 0 .05 1 . 35 + 0. 06 
Pyruvate 0.047 + 0. 003 0. 1 1 9 + 0. 01 1 0. 10 + 0 .01 0. 1 3 + 0. 01 
L a c t a t e 1 .95 0. 09 3. 29 0. 1 5 3 . 67 + 0 . 1 3 6, 10 + 0. 17 
AcAc 0.049 + 0. 004 0. 053 + 0. 007 0. 061 + 0 .005 0. 060 + 0. 005 
6-HO-Bu 0.19 + 0. 01 0. 16 + 0. 01 0. 1 7 + 0 .01 0. 3 2 + 0. 02 
G-3-P/DAP 1 4 . 8 14 .6 16 .3 35 . 5 
L a c t / P y r u v a t e 41 . 5 27 .5 36 . 7 47 .0 
6-HO-Bu/AcAc 3 .9 3 .0 2 .8 5 . 3 
Content of metabolites (y moles/g t i s s u e ) i n mouse l i v e r a f t e r i . p . i n j e c t i o n 
of 6 mg/g body weight glucose and hyperthermia f o r one hour. 
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Table 2 
Control Hyperthermia 
d i r e c t l y a f t e r 
Hypertherm.ia 
Glucose 
60 minutes 
Glucose + 
Hyperthermia 
60 min, a f t e r 
i n j e c t i o n 
d i r e c t l y a f t e r 
Glucose 3.12 0. 10 1.19 + 0 .14 10.96 + 1 .19 7.99 + 0. 47 
G-6-P 1 .02 0. 03 0.65 -1- 0 .04 0.70 + 0 .03 1.10 + 0. 10 
FDP 0.030 + 0. 001 0,027 -r 0 .003 0,048 + 0 .002 0.061 0. 002 
DAP 0.036 + 0. 001 0.030 + 0 .002 0.046 + 0 .002 0.054 + 0. 002 
G-3-P 0.37 + 0. 01 0.50 0 .02 0.36 + 0 .01 0.58 + 0. 01 
Pyruvate 0.22 + 0. 01 0.22 + 0 .01 0. 20 + 0 .01 0.17 + 0. 01 
L a c t a t e 14.3 + 0. 3 13.1 + 0 .5 16.5 0 .5 26.5 0. 6 
AcAc 0.017 4- 0. 002 0.016 + 0 .003 0.018 + 0 .002 0.014 + 0. 002 
6-HO-Bu 0.097 0. 007 0. 159 + 0 .008 0.06 9 + 0 .004 0.15 + 0. 01 
G-3-P/DAP 10 .2 16 . 7 7 . 8 10 . 4 
L a c t / P y r u v a t e 65 60 82 156 
6-HO-Bu/AcAc 5 .7 10 .0 3 . 8 10 .7 
Content of metabolites (y moles/g t i s s u e ) i n tran s p l a n t e d adenocarcinomas a f t e r 
i . p . i n j e c t i o n of 6 mg/g body weight glucose and hyperthermia f o r one hour. 
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Table 3 
Control 1 hour 6 hours 12 hours 
Glucose 3.12 + 0. 10 1 . 59 + 0 .12 1 . 35 + 0 .08 1 .04 0 .06 4 
G-6-P 1 .02 -t- 0. 03 0. 70 + 0 .04 0.90 + 0 .046 0 .44 + 0 .036 
FDP 0.030 0. 001 0. 022 + 0 .002 0.027 + 0 .001 0 .017 + 0 .001 
DAP 0.036 + 0. 001 0, 029 + 0 .002 0.029 + 0 .002 0 .023 + 0 .002 
G-3-P 0. 37 + 0. 01 0. 31 + 0 .01 0. 37 + 0 .02 0 .28 + 0 .01 2 
Pyruv a t e 0.22 + 0. 01 0. 24 + 0 .01 0.17 + 0 .01 0 . 1 1 + 0 .01 
L a c t a t e 14.3 + 0. 3 11 . 9 - i - 0 . 4 12.1 - 0 . 4 7 .90 + 0 . 30 
AcAc 0.01 7 + 0. 002 0. 041 -f- 0 .007 0.058 0 .009 0 .19 + 0 .02 
6-HO-Bu 0.097 + 0. 007 0. 249 + 0 .027 0.338 + 0 .030 0 .75 + 0 .07 
G-3-P/DAP 14 . 8 10 .7 1 2 . 8 1 2 . 1 
L a c t / P y r 41 .5 49 .6 36 .7 46 .7 
6-HO-Bu/AcAc 3 .9 6 . 1 5 .9 4 .9 
Content of metabolites (y moles/g t i s s u e ) i n tr a n s p l a n t e d adenocarcinomas a f t e r 
hyperthermia f o r one hour. 
